Data is not available at this time.
CEDAR.Co.,Ltd. operates in Japan's growing elderly care sector, providing a comprehensive suite of nursing and rehabilitation services. The company's revenue model is built on fee-for-service arrangements, covering day care, resident life care, home-visit nursing, and short-term residency care. As Japan's aging population expands, demand for such services is rising, positioning CEDAR as a key player in a structurally supportive market. The company differentiates itself through localized service networks and integrated care solutions, catering to both private-pay and government-subsidized clients. Its focus on home-based and community care aligns with Japan's policy shift away from institutionalization, enhancing its long-term relevance. However, the sector remains fragmented, with regional competition and regulatory oversight influencing profitability. CEDAR's mid-sized scale allows agility in adapting to demographic shifts while maintaining operational control over service quality—a critical factor in reputation-sensitive healthcare markets.
For FY2024, CEDAR reported revenue of JPY 17.3 billion, with net income of JPY 203 million, reflecting tight margins in the capital-intensive care sector. Operating cash flow stood at JPY 1.47 billion, partially offset by JPY 479 million in capital expenditures. The modest net income suggests cost pressures from labor and facility maintenance, common in Japan's care industry where staffing costs account for ~60-70% of expenses.
Diluted EPS of JPY 18.09 indicates limited but stable earnings capacity, typical for regulated care providers. The company's capital efficiency is constrained by high fixed costs for facilities and equipment, though its cash flow generation supports ongoing operations. Debt servicing costs likely weigh on net margins given JPY 15.2 billion in total debt.
With JPY 1.64 billion in cash against JPY 15.2 billion debt, leverage appears elevated, though common for care operators financing real estate and equipment. The debt load may reflect expansion needs in a sector requiring upfront infrastructure investments. Liquidity seems adequate with positive operating cash flow covering interest obligations.
Growth is tied to Japan's aging demographics, with organic expansion possible through new care centers. A JPY 6/share dividend implies a ~33% payout ratio, balancing shareholder returns with reinvestment needs. Future growth may require selective acquisitions or government partnership models to mitigate capex burdens.
At a JPY 2.44 billion market cap, the stock trades at ~12x net income, reflecting sector risks like labor shortages and reimbursement pressures. The negative beta suggests defensive characteristics, though limited earnings scalability may cap valuation upside.
CEDAR's regional expertise and diversified service portfolio provide resilience, but success hinges on navigating staffing challenges and reimbursement policies. Strategic priorities likely include operational digitization and partnerships to improve margins. Long-term prospects remain favorable given demographic trends, but execution risks persist.
Company filings, Japan healthcare sector reports
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |